The World Market for Cyclanic, Cyclenic or Cycloterpenic Mono- or Polyamines, Their Derivatives, and Salts Thereof: A 2024 Global Trade Perspective
This report was created for strategic planners, international executives, and import/export managers who are concerned with the market for cyclanic, cyclenic or cycloterpenic mono- or polyamines, their derivatives, and salts thereof. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD, has developed a methodology, based on macroeconomic and trade models, to estimate the market for cyclanic, cyclenic or cycloterpenic mono- or polyamines, their derivatives, and salts thereof for those countries serving the world market via exports or supplying from various countries via imports. He does so for the current year based on a variety of key historical indicators and econometric models.
"Cyclanic, cyclenic or cycloterpenic mono- or polyamines, their derivatives, and salts thereof" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "cyclanic, cyclenic or cycloterpenic mono- or polyamines, their derivatives, and salts thereof" is 51453.
1 METHODOLOGY
1.1 OUR APPROACH
2 THE WORLD MARKET
2.1 EXPORTS
2.1.1 THE WORLD MARKET: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF EXPORT SUPPLIES IN 2024
2.2 IMPORTS
2.2.1 THE WORLD MARKET: IMPORTED CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3 EXPORTS
3.1 AFRICA: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.1.1 EXECUTIVE SUMMARY
3.1.2 SOUTH AFRICA
3.2 ASIA: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.2.1 EXECUTIVE SUMMARY
3.2.2 CHINA
3.2.3 HONG KONG
3.2.4 INDIA
3.2.5 JAPAN
3.2.6 MALAYSIA
3.2.7 SINGAPORE
3.2.8 SOUTH KOREA
3.2.9 TAIWAN
3.2.10 THAILAND
3.3 EUROPE: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.3.1 EXECUTIVE SUMMARY
3.3.2 AUSTRIA
3.3.3 BELGIUM
3.3.4 BULGARIA
3.3.5 CROATIA
3.3.6 DENMARK
3.3.7 FRANCE
3.3.8 GERMANY
3.3.9 HUNGARY
3.3.10 IRELAND
3.3.11 ITALY
3.3.12 LATVIA
3.3.13 POLAND
3.3.14 PORTUGAL
3.3.15 RUSSIA
3.3.16 SLOVAKIA
3.3.17 SLOVENIA
3.3.18 SPAIN
3.3.19 SWEDEN
3.3.20 SWITZERLAND
3.3.21 THE CZECH REPUBLIC
3.3.22 THE NETHERLANDS
3.3.23 THE UNITED KINGDOM
3.4 LATIN AMERICA: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.4.1 EXECUTIVE SUMMARY
3.4.2 ARGENTINA
3.4.3 BRAZIL
3.5 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.5.1 EXECUTIVE SUMMARY
3.5.2 CANADA
3.5.3 THE UNITED STATES
3.6 OCEANIA: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.6.1 EXECUTIVE SUMMARY
3.6.2 AUSTRALIA
3.6.3 NEW ZEALAND
3.7 THE MIDDLE EAST: EXPORT SUPPLIES OF CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IN 2024
3.7.1 EXECUTIVE SUMMARY
3.7.2 ISRAEL
3.7.3 SAUDI ARABIA
3.7.4 THE UNITED ARAB EMIRATES
4 IMPORTS
4.1 AFRICA: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.1.1 EXECUTIVE SUMMARY
4.1.2 ALGERIA
4.1.3 EGYPT
4.1.4 MOROCCO
4.1.5 NAMIBIA
4.1.6 SOUTH AFRICA
4.2 ASIA: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.2.1 EXECUTIVE SUMMARY
4.2.2 CHINA
4.2.3 HONG KONG
4.2.4 INDIA
4.2.5 INDONESIA
4.2.6 JAPAN
4.2.7 MALAYSIA
4.2.8 SINGAPORE
4.2.9 SOUTH KOREA
4.2.10 TAIWAN
4.2.11 THAILAND
4.2.12 THE PHILIPPINES
4.2.13 VIETNAM
4.3 EUROPE: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.3.1 EXECUTIVE SUMMARY
4.3.2 AUSTRIA
4.3.3 BELARUS
4.3.4 BELGIUM
4.3.5 BULGARIA
4.3.6 CROATIA
4.3.7 CYPRUS
4.3.8 DENMARK
4.3.9 FINLAND
4.3.10 FRANCE
4.3.11 GERMANY
4.3.12 GREECE
4.3.13 HUNGARY
4.3.14 IRELAND
4.3.15 ITALY
4.3.16 KAZAKHSTAN
4.3.17 LATVIA
4.3.18 LITHUANIA
4.3.19 MACEDONIA
4.3.20 MALTA
4.3.21 NORWAY
4.3.22 POLAND
4.3.23 PORTUGAL
4.3.24 ROMANIA
4.3.25 RUSSIA
4.3.26 SLOVAKIA
4.3.27 SLOVENIA
4.3.28 SPAIN
4.3.29 SWEDEN
4.3.30 SWITZERLAND
4.3.31 THE CZECH REPUBLIC
4.3.32 THE NETHERLANDS
4.3.33 THE UNITED KINGDOM
4.3.34 UKRAINE
4.4 LATIN AMERICA: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.4.1 EXECUTIVE SUMMARY
4.4.2 ARGENTINA
4.4.3 BOLIVIA
4.4.4 BRAZIL
4.4.5 CHILE
4.4.6 COLOMBIA
4.4.7 ECUADOR
4.4.8 EL SALVADOR
4.4.9 GUATEMALA
4.4.10 MEXICO
4.4.11 PARAGUAY
4.4.12 PERU
4.4.13 URUGUAY
4.5 NORTH AMERICA & THE CARIBBEAN: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.5.1 EXECUTIVE SUMMARY
4.5.2 CANADA
4.5.3 THE UNITED STATES
4.6 OCEANIA: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.6.1 EXECUTIVE SUMMARY
4.6.2 AUSTRALIA
4.6.3 NEW ZEALAND
4.7 THE MIDDLE EAST: CYCLANIC, CYCLENIC OR CYCLOTERPENIC MONO- OR POLYAMINES, THEIR DERIVATIVES, AND SALTS THEREOF IMPORTS IN 2024
4.7.1 EXECUTIVE SUMMARY
4.7.2 BAHRAIN
4.7.3 ISRAEL
4.7.4 JORDAN
4.7.5 KUWAIT
4.7.6 OMAN
4.7.7 PAKISTAN
4.7.8 QATAR
4.7.9 TURKEY
5 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
5.1 DISCLAIMERS & SAFE HARBOR
5.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS